Activity aim
In this clinical audit, you will identify patients with COPD who have a history of moderate to severe exacerbations in the past 12 months and an increased risk of cardiovascular events. You will consider how your patient’s self-management behaviours, inhaled COPD medications and prescribed non-pharmacological treatments could be further optimised, in line with evidence-based guidelines, to improve symptom control and reduce the risk of further exacerbations.
Why take part in this program?
- Access a comprehensive pre-learning activity presented by Conjoint A/Prof Chee Khoo and Conjoint A/Prof Belinda Cochrane
- Identify five suitable patients for this activity who have previously been diagnosed with chronic obstructive pulmonary disease
- Earn 6.5 CPD hours upon completion.
Inclusion criteria
Patients who are eligible for this clinical audit are adults who are:
- aged 18 years or older
- previously diagnosed with COPD
- 1 or more severe COPD exacerbations requiring hospitalisation in past 12 months, OR 2 or more moderate exacerbations in the past 12 months
How long should it take?
The program has been designed to take approximately 4-6 weeks to complete. This includes patient recall from your practice, patient consult and program evaluation.
Tips to recruit patients
Recruitment may occur:
- Opportunistically as you consult appropriate patients as part of usual care.
- By active recall.
This activity will be closing on 24/04/2026. Please complete ASAP so your CPD can be awarded.
Learning outcomes
Presenters
An educator with a special interest in chronic disease, Conjoint A/Prof Khoo has been a practicing solo GP in Ingleburn since 1990. He is the Chair of the Education Working Group at the Diabetes, Obesity and Metabolism Translational Research Unit (DOMTRU). He is a member of the RACGP’s Specific Interest Groups in Diabetes and Obesity Management and the Editor-in-chief at GPVoice.com.au
Conjoint A/Prof Belinda Cochrane is a Respiratory & Sleep Medicine Staff Specialist at Camden and Campbelltown Hospitals in Sydney. She is an SME reviewer for the COPD-X Guidelines Committee for cardiology related respiratory papers, and a member of the Statewide Respiratory Network in New South Wales. Her research interests include COPD and its relationship with cardiac disease, breathlessness and inhaler device capability.
